Argent Ventures

Argent Ventures is a privately held, vertically-integrated real estate investment and development firm founded in 1997 and headquartered in New York City. The firm specializes in opportunistic, value-add, and core transactions across various asset classes, including office, retail, industrial, hotel, residential, and specialty facilities such as data centers and laboratories. Since its inception, Argent Ventures has invested over $3.0 billion in real estate assets and debt instruments in major markets in the United States and Europe.

The firm's investment strategy focuses on identifying and unlocking value in distressed properties, with a track record of quick and efficient transactions, particularly in special situations and complex debt workouts. Argent Ventures has been involved in notable projects, including the acquisition of the fee position of New York’s Grand Central Terminal in 2007, and the development of a successful portfolio of data centers in the U.S. and Europe in the late 1990s. Additionally, the firm was an early investor in the life sciences sector, acquiring the laboratory and office park that would become the world headquarters of Regeneron Pharmaceuticals.

Argent Ventures' approach is characterized by active, hands-on asset management, enabling the firm to create value for its partners and investors. The firm has substantial equity available for investment and is known for its nimble and entrepreneurial approach to deal-making, with a focus on specific supply-constrained metropolitan markets where it has previous acquisition and operational experience, including greater New York City, Los Angeles, and Miami/Ft. Lauderdale.